D. Abraham

发表

The consequences of scoring docked ligand conformations using free energy correlations.

F. Spyrakis, Alessio Amadasi, M. Fornabaio, 2007, European journal of medicinal chemistry.

Free energy of ligand binding to protein: evaluation of the contribution of water molecules by computational methods.

Anna Marabotti, Pietro Cozzini, Glen E Kellogg, 2004, Current medicinal chemistry.

Inhibition of Sickle Hemoglobin Polymerization as a Basis for Therapeutic Approaches to Sickle‐Cell Anemia

A. Schechter, D. Abraham, J. Haley, 2003 .

Extension of the fragment method to calculate amino acid zwitterion and side chain partition coefficients

A. Leo, D. Abraham, D J Abraham, 1987, Proteins.

Hydropathic analysis of the non-covalent interactions between molecular subunits of structurally characterized hemoglobins.

G E Kellogg, G. K. Ackers, D. Abraham, 1997, Journal of molecular biology.

Hydrophobicity: is LogPo/w more than the sum of its parts?

Glen E. Kellogg, Donald J. Abraham, D. Abraham, 2000 .

Computational methodology for estimating changes in free energies of biomolecular association upon mutation. The importance of bound water in dimer-tetramer assembly for beta 37 mutant hemoglobins.

G E Kellogg, D. Abraham, G. Kellogg, 2000, Biochemistry.

Computationally accessible method for estimating free energy changes resulting from site‐specific mutations of biomolecules: Systematic model building and structural/hydropathic analysis of deoxy and oxy hemoglobins

G E Kellogg, D. Abraham, G. Kellogg, 2001, Proteins.

Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes.

Pietro Cozzini, Glen E Kellogg, Donald J Abraham, 2003, Journal of medicinal chemistry.

Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water molecules in HIV-1 protease complexes.

Pietro Cozzini, Glen E Kellogg, Francesca Spyrakis, 2004, Journal of medicinal chemistry.

Computational titration analysis of a multiprotic HIV-1 protease-ligand complex.

Pietro Cozzini, Glen E Kellogg, Francesca Spyrakis, 2004, Journal of the American Chemical Society.

Mapping the energetics of water-protein and water-ligand interactions with the "natural" HINT forcefield: predictive tools for characterizing the roles of water in biomolecules.

Pietro Cozzini, Glen E Kellogg, Francesca Spyrakis, 2006, Journal of molecular biology.

The Rationale for, and Effects of Oxygen Delivery Enhancement to Ischemic Brain in a Feline Model of Human Stroke a

D. Abraham, E. Doppenberg, J. Watson, 1997, Annals of the New York Academy of Sciences.

Getting it right: modeling of pH, solvent and "nearly" everything else in virtual screening of biological targets.

Pietro Cozzini, Glen E Kellogg, Francesca Spyrakis, 2004, Journal of molecular graphics & modelling.

Increased radiation response of FSaII fibrosarcomas in C3H mice following administration of an allosteric effector of hemoglobin-oxygen affinity

R. Schmidt-Ullrich, D. Abraham, P. Lin, 1996 .

Burger's medicinal chemistry, drug discovery, and development

Donald J. Abraham, A. Burger, D. Abraham, 2010 .

Vanillin, a potential agent for the treatment of sickle cell anemia

D. Abraham, E. Orringer, F. Wireko, 1991 .

Vanillin, a potential agent for the treatment of sickle cell anemia.

D. Abraham, E. Orringer, F. Wireko, 1991, Blood.

5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells †,‡

D. Abraham, C. Brugnara, M. Safo, 2005, British journal of haematology.

Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin. Corrigendum

D. Abraham, F. Musayev, M. Safo, 2011, Acta crystallographica. Section D, Biological crystallography.

The crystal structure of uridine

R. E. Marsh, B. Trus, D. Abraham, 1975 .

Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.

D. Abraham, R. Schmidt-Ullrich, P. Lin, 1993, The American journal of physiology.

Single crystal x-ray structure of chemotherapeutic agents IV, the structure of 6-chloro-9-(3,4-di--acetyl-2-deoxy-β-d-ribopyranosyl)purine ☆

D. Abraham, L. Townsend, E. Leutzinger, 1971 .

Drug Discovery in Academia – A Case Study

D. Abraham, 2005 .

Comparison of crystal and solution hemoglobin binding of selected antigelling agents and allosteric modifiers.

D. Abraham, A. Mehanna, 1990, Biochemistry.

Synthesis and X-ray studies of chiral allosteric modifiers of hemoglobin.

D. Abraham, M. Marden, M. Safo, 2002, Journal of medicinal chemistry.

Modulating the oxygen affinity of human fetal haemoglobin with synthetic allosteric modulators

I. Papassotiriou, D. Abraham, M. Marden, 1998, British journal of haematology.

Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.

D. Abraham, R. Randad, A. Mehanna, 1991, Journal of medicinal chemistry.

Pyridyl Derivatives of Benzaldehyde as Potential Antisickling Agents

D. Abraham, M. Safo, T. Asakura, 2008, Chemistry & biodiversity.

Neurochemistry of aging. 1. Toxins for an animal model of Alzheimer's disease.

D. Abraham, J. Mistry, I. Hanin, 1986, Journal of medicinal chemistry.

The X-ray structure determination of bovine carbonmonoxy hemoglobin at 2.1 A resoultion and its relationship to the quaternary structures of other hemoglobin crystal froms.

D. Abraham, M. Safo, 2001, Protein science : a publication of the Protein Society.

Structural Analogs of AF64A: Synthesis and their Effects on High Affinity Choline Transport and QNB Binding

D. Abraham, J. Mistry, I. Hanin, 1986 .

Proposed detailed structural model for tRNA and its geometric relationship to a messenger.

D. Abraham, 1971, Journal of theoretical biology.

A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics.

E. Shaw, D. Abraham, K. Dusenbery, 2001, International journal of radiation oncology, biology, physics.

Design, synthesis, and testing of potential antisickling agents. 9. Cyclic tetrapeptide homologs as mimics of the mutation site of hemoglobin S.

D. Abraham, L. Sheh, M. Mokotoff, 2009, International journal of peptide and protein research.

Design, synthesis, and testing of potential antisickling agents. 3. Ethacrynic acid.

D. Abraham, P. Kennedy, F. Williams, 1984, Journal of medicinal chemistry.

Design, synthesis, and testing of antisickling agents. 2. Proline derivatives designed for the donor site.

D. Abraham, L. Sheh, M. Mokotoff, 1983, Journal of medicinal chemistry.

Design, synthesis, and testing of potential antisickling agents. 1. Halogenated benzyloxy and phenoxy acids.

D. Abraham, F. Williams, A. Mehanna, 1982, Journal of medicinal chemistry.

The structure of silydianin, an isomer of silymarin (silybin), by x-ray analysis

H. Wagner, D. Abraham, N. Farnsworth, 1970 .

Catharanthus alkaloids. XXIX. Isolation and structure elucidation of vincoline.

G. Cordell, D. Abraham, N. Farnsworth, 1974, Journal of pharmaceutical sciences.

Novel Six-Ring Compounds Via The Reaction of Ketene Diethylacethal with methanesulfonyl chloride

D. Abraham, P. S. Radhakrishnamurti, W. E. Truce, 1963 .

Cannabisativine, a new alkaloid from cannabis sativa l. root

D. Abraham, P. Schiff, C. Turner, 1975 .

Molecular structure and conformation of the nucleoside antibiotic derivative 2-methylformycin with a C-glycosidic bond.

D. Abraham, M. Sims, J. Abola, 1974, Journal of medicinal chemistry.

The Cycloaddition of Sulfene to Ketene Diethylacetal

D. Abraham, W. E. Truce, J. R. Norell, 1962 .

The stereochemistry of the reaction of tetrachloroethylene with p-toluene-thiolate reagent☆

M. Rossmann, D. Abraham, R. M. Burnett, 1965 .

A nonpeptidic sulfonamide inhibits the p53-mdm2 interaction and activates p53-dependent transcription in mdm2-overexpressing cells.

Donald J Abraham, D. Abraham, Peter S Galatin, 2004, Journal of medicinal chemistry.

Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.

Anna Marabotti, Pietro Cozzini, Glen E Kellogg, 2002, Journal of medicinal chemistry.

Reactions of sulfenes with ketene acetals and ketene animals.

D. Abraham, W. E. Truce, P. Son, 1967, The Journal of organic chemistry.

Evaluation of the side arm of (naphthylvinyl)pyridinium inhibitors of choline acetyltransferase.

D. Abraham, P. Gifford, J. Debernardis, 1988, Journal of medicinal chemistry.

The structure elucidation of Rhazinilam, a new class of Alkaloids from the apocynaceae, by X-ray analysis

R. L. Lyon, D. Abraham, H. Fong, 1972 .

Bisaldehyde allosteric effectors as molecular ratchets and probes.

D. Abraham, M. Safo, J. Kister, 1995, Biochemistry.

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

J. Pettegrew, W. Klunk, D. Abraham, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Biological and phytochemical evaluation of plants. IX. Antitumor activity of Maytenus senegalensis (Celastraceae) and a preliminary phytochemical investigation.

D. Abraham, R. N. Blomster, N. Farnsworth, 1971, Lloydia.

Structure elucidation of maytenonic acid, a new triterpene from Maytenus senegalensis (celastraceae).

D. Abraham, N. Farnsworth, H. Fong, 1971, Journal of pharmaceutical sciences.

Structure-Based Drug Design – A Historical Perspective and the Future

D. J. Abraham, D. Abraham, 2007 .

Structure of human erythrocyte catalase.

Changqing, D. Abraham, T. Ko, 2000, Acta crystallographica. Section D, Biological crystallography.

Single crystal studies of chemotherapeutic agents. I. The structure of 1-(2-chloroethyl)-3-(5-carbamoylimidazol-4-yl)-delta 2-1,2,3-triazolinium chloride.

D. Abraham, J. S. Rutherford, R. Rosenstein, 1969, Journal of medicinal chemistry.

Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.

D. Abraham, M. Safo, Hsiang-Ru Lin, 2007, Bioorganic & medicinal chemistry letters.

Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam. (Rutaceae).

D. Abraham, N. Farnsworth, H. Fong, 1972, Journal of pharmaceutical sciences.

Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.

D. Abraham, Hsiang-Ru Lin, 2006, Bioorganic & medicinal chemistry letters.

Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids.

D. Abraham, M. Fatope, 1987, Journal of medicinal chemistry.

Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N‐butylated derivative on normal and sickle erythrocytes

D. Abraham, E. Orringer, D. Blythe, 1992, American journal of hematology.

Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.

D. Abraham, A. Fisher, C. Mantione, 1982, The Journal of pharmacology and experimental therapeutics.

Newer Methods in Preparative Organic Chemistry.

D. Abraham, 1964 .

Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site.

D. Abraham, M. Mokotoff, P. Kennedy, 1984, Journal of medicinal chemistry.

Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.

D. Abraham, F. Musayev, M. Safo, 2003, Journal of medicinal chemistry.

How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.

D. Abraham, M. Safo, J. Kister, 1995, Biochemistry.

Structure elucidation and chemistry of Catharanthus alkaloids. IV. Structures of hoerhammericine and hoerhammerinine

D. Abraham, R. N. Blomster, N. Farnsworth, 1969 .

Physiological and x-ray studies of potential antisickling agents.

M. Perutz, D. Abraham, S. Phillips, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Structure of relaxed-state human hemoglobin: insight into ligand uptake, transport and release.

D. Abraham, F. Musayev, M. Safo, 2009, Acta crystallographica. Section D, Biological crystallography.

Identification of Novel Allosteric Regulators of Human‐Erythrocyte Pyruvate Kinase

M. Fornabaio, D. Abraham, F. Musayev, 2007, Chemistry & biodiversity.

Control of the allosteric equilibrium of hemoglobin by cross‐linking agents

D. Abraham, L. Kiger, M. Marden, 2002, Protein science : a publication of the Protein Society.

X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.

D. Abraham, M. Safo, J. Burnett, 2001, Acta crystallographica. Section D, Biological crystallography.

Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.

A. Galizzi, A. Zanella, D. Abraham, 2001, Blood.

Single-crystal x-ray structure of chemotherapeutic agents. V. Structures of 5-diazo-6-methoxy-6-hydrouracil and 2'-deoxy-5-diazo-6-hydro-065'-cyclouridine hemihydrate

D. Abraham, R. Rosenstein, T. Cochran, 1971 .

Structure elucidation of periformyline, a novel alkaloid from . .

D. Abraham, R. N. Blomster, N. Farnsworth, 1965 .

HINT: A new method of empirical hydrophobic field calculation for CoMFA

Glen Eugene Kellogg, Donald J. Abraham, Simon F. Semus, 1991, J. Comput. Aided Mol. Des..

Structure Elucidation and Chemistry of Catharanthus Alkaloids II. Isolation and Partial Structure of Catharine, a Dimeric Indole Alkaloid From C. Zanceus and C. Roseus

D. Abraham, R. N. Blomster, N. Farnsworth, 1967 .

Catharanthus lanceus VII. Isolation of tetrahydroalstonine, lochnerinine, and periformyline.

D. Abraham, R. N. Blomster, N. Farnsworth, 1965, Journal of pharmaceutical sciences.

Structure elucidation and chemistry of Catharanthus alkaloids. 3. Structure of leurosine, an active anticancer alkaloid.

D. Abraham, N. Farnsworth, 1969, Journal of pharmaceutical sciences.

Target flexibility: an emerging consideration in drug discovery and design.

Holger Gohlke, Garrett M Morris, Francesca Fanelli, 2008, Journal of medicinal chemistry.

QSAR: Hydropathic analysis of inhibitors of the p53–mdm2 interaction

D. Abraham, P S Galatin, D J Abraham, 2001, Proteins.

3,4-Dichlorobenzyloxyacetic acid is extensively metabolized to a taurine conjugate in rats.

D. Abraham, J. Alvin, R. Peffer, 1987, Drug metabolism and disposition: the biological fate of chemicals.

Structure of human carbonmonoxyhemoglobin at 2.16 A: a snapshot of the allosteric transition.

D. Abraham, F. Musayev, M. Safo, 2002, Acta crystallographica. Section D, Biological crystallography.

The X‐ray structure determination of bovine carbonmonoxy hemoglobin at 2.1 Å resoultion and its relationship to the quaternary structures of other hemoglobin crystal forms

D. Abraham, M. Safo, 2001 .

Table 1. Effect of LlBr on HomozygousHbS Erythrocytes

D. Abraham, D. C. Patwa, 1985 .

Structure and Function of Human Erythrocyte Pyruvate Kinase

Laurent R. Chiarelli, Andrea Mattevi, Donald J. Abraham, 2002, The Journal of Biological Chemistry.

Structures of R- and T-state hemoglobin Bassett: elucidating the structural basis for the low oxygen affinity of a mutant hemoglobin.

D. Abraham, M. Safo, T. Asakura, 2005, Acta crystallographica. Section D, Biological crystallography.

Characterization of hemoglobin bassett (α94Asp→Ala), a variant with very low oxygen affinity

N. B. Lerner, D. Abraham, E. Daikhin, 2004, American journal of hematology.

Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke.

D. Abraham, M. Bullock, H. Young, 1997, Stroke.

Low-affinity hemoglobin increases tissue PO2 and decreases arteriolar diameter and flow in the rat cremaster muscle.

D. Abraham, J. Lombard, M. P. Kunert, 1996, Microvascular research.

High–resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector

D. Abraham, M. Safo, J. Burnett, 2000, Protein science : a publication of the Protein Society.

The enigma of the liganded hemoglobin end state: a novel quaternary structure of human carbonmonoxy hemoglobin.

D. Abraham, M. Safo, D J Abraham, 2005, Biochemistry.

Hemoglobin as a Receptor of Drugs and Peptides: X-Ray Studies of the Stereochemistry of Binding.

M. Perutz, D. Abraham, G. Fermi, 2002 .

RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats.

D. Abraham, M. P. Kunert, J. Liard, 1996, The American journal of physiology.

Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.

D. Abraham, J. Kister, C. Poyart, 1992, Biochemistry.

X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals.

D. Abraham, R. Peascoe, R. Randad, 1992, Journal of molecular biology.

A Reply Dietary Management of Sickle Cell Anaemia with Vanillin

D. Abraham, P. Swerdlow, E. Orringer, 1992 .

X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin.

D. Abraham, F. Wireko, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.

D. Abraham, D. C. Patwa, T. Hung, 1987, Blood cells.

DESIGN, SYNTHESIS, AND TESTING OF POTENTIAL ANTISICKLING AGENTS. 5. DISUBSTITUTED BENZOIC ACIDS DESIGNED FOR THE DONOR SITE AND PROLINE SALICYLATES DESIGNED FOR THE ACCEPTOR SITE

D. Abraham, M. Mokotoff, P. Kennedy, 1985 .

RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice

D. Abraham, R. Schmidt-Ullrich, P. Lin, 1999, British Journal of Cancer.

Structure-based drug design strategies in medicinal chemistry.

Donald J Abraham, Adriano D Andricopulo, Lívia B Salum, 2009, Current topics in medicinal chemistry.

KEY, LOCK, and LOCKSMITH: complementary hydropathic map predictions of drug structure from a known receptor-receptor structure from known drugs.

G E Kellogg, D. Abraham, G. Kellogg, 1992, Journal of molecular graphics.

Tools for building a comprehensive modeling system for virtual screening under real biological conditions: The Computational Titration algorithm.

F. Spyrakis, M. Fornabaio, D. Abraham, 2006, Journal of molecular graphics & modelling.

Structure of tetragonal crystals of human erythrocyte catalase.

D. Abraham, T. Ko, F. Musayev, 2000, Acta crystallographica. Section D, Biological crystallography.

Crystallization and preliminary X-ray crystallographic analysis of pyridoxine 5'-phosphate oxidase complexed with flavin mononucleotide.

D. Abraham, F. Musayev, M. Safo, 1999, Journal of structural biology.

Stereochemical Characterization of the Diastereomers of the Amobarbital N-Glucosides Excreted in Human Urine

D. Abraham, F. Wireko, W. Soine, 1990, Pharmaceutical Research.

Very empirical treatment of solvation and entropy: a force field derived from Log Po/w

Glen Eugene Kellogg, Donald J. Abraham, James C. Burnett, 2001, J. Comput. Aided Mol. Des..

Two simple methods for quantifying low-affinity dye-substrate binding.

J. Pettegrew, W. Klunk, D. Abraham, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.

D. Abraham, P. Kennedy, F. Williams, 1984, Journal of medicinal chemistry.

Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.

D. Abraham, T. Asakura, M. P. Reilly, 1998, The Japanese journal of physiology.

X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with FMN at 1.8 A resolution.

D. Abraham, F. Musayev, I. Mathews, 2000, Structure.

The effect of physical organic properties on hydrophobic fields

Glen Eugene Kellogg, Donald J. Abraham, D. Abraham, 1994, J. Comput. Aided Mol. Des..

High-performance liquid chromatographic method for determination of vanillin and vanillic acid in human plasma, red blood cells and urine.

D. Abraham, P. Swerdlow, D. Sica, 1999, Journal of chromatography. B, Biomedical sciences and applications.

X-ray crystallography of hemoglobins.

D. Abraham, M. Safo, 2003, Methods in molecular medicine.

Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors.

G E Kellogg, D. Abraham, G. Kellogg, 1991, Journal of medicinal chemistry.

Solubility properties in polymers and biological media. 8. An analysis of the factors that influence toxicities of organic nonelectrolytes to the golden orfe fish (Leuciscus idus melanotus)

Michael H. Abraham, Gilman D. Veith, Ruth M. Doherty, 1987 .

Burger's medicinal chemistry and drug discovery ( Vol- 5 : chemotherapeutic agents )

D. Abraham, 2003 .

The crystal state binding of dithionite to deoxy-hemoglobin.

D. Abraham, F. Wireko, 1992, Protein engineering.

Intrinsic activity at the molecular level: E. J. Ariëns' concept visualized.

D. Abraham, M. Marden, J. Kister, 1995, Journal of molecular biology.

Studies on Nigerian plants. 3. Biological and phytochemical screening of Lophira lanceolata, and the isolation of benzamide.

D. Abraham, R. N. Blomster, N. Farnsworth, 1967, Planta medica.

Methylphenylmercury: a novel heavy atom reagent for protein crystallography.

D. Abraham, S. Phillips, P. Kennedy, 1983, Journal of molecular biology.

Water: How to evaluate its contribution in protein–ligand interactions

Pietro Cozzini, Francesca Spyrakis, Glen E. Kellogg, 2006 .

New Application Design for a 3D Hydropathic Map-Based Search for Potential Water Molecules Bridging between Protein and Ligand #

M. Fornabaio, D. Abraham, G. Kellogg, 2005 .

Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities

Elaine C. Meng, Irwin D. Kuntz, Glen Eugene Kellogg, 1994, J. Comput. Aided Mol. Des..

Hydrophobicity: is LogP(o/w) more than the sum of its parts?

D. Abraham, G. Kellogg, D J Abraham, 2000, European journal of medicinal chemistry.

Effect of distamycin on chlorambucil-induced mutagenesis in pZ189: evidence of a role for minor groove alkylation at adenine N-3.

D. Abraham, G. Kellogg, L. Povirk, 1994, Mutagenesis.

Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin.

D. Abraham, M. Marden, M. Safo, 2000, Journal of Medicinal Chemistry.

Design, synthesis, and testing of potential antisickling agents. 7. Ethacrynic acid analogues.

D. Abraham, E. Cragoe, O. W. Woltersdorf, 1989, Journal of medicinal chemistry.

Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding

Max F. Perutz, Donald J. Abraham, M. Perutz, 1986 .

Effect of local change in O2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension.

D. Abraham, H. Kontos, E. P. Wei, 1993, The American journal of physiology.

Isolation of hörhammericine fromC. lanceus (Apocynaceae) roots

D. Abraham, R. N. Blomster, N. Farnsworth, 1968, Naturwissenschaften.

Catharanthus alkaloids. X. Isolation of lanceine and vinosidine from Catharanthus lanceus roots.

D. Abraham, R. N. Blomster, N. Farnsworth, 1967, Journal of pharmaceutical sciences.

Single crystal x-ray structures of chemotherapeutic agents. 3. Structure of 1,4-diazabicyclo[2.2.1]heptanes, a new heterocyclic ring system.

D. Abraham, G. Pettit, R. Rosenstein, 1971, Journal of medicinal chemistry.

Solubility properties in polymers and biological media: 6. An equation for correlation and prediction of solubilities of liquid organic nonelectrolytes in blood.

R. Taft, M. J. Kamlet, R. Doherty, 1986, Journal of pharmaceutical sciences.

The X-ray crystal and molecular structure of the nucleoside β-uridine

D. Abraham, E. A. Green, R. Rosenstein, 1971 .

Filamentous proteins in Alzheimer's disease: new insights through molecular biology.

W. Klunk, D. Abraham, 1988, Psychiatric developments.

Molecular structure and conformation of the nucleoside antibiotic derivative 2-methylformycin with a C-glycosidic bond.

D. Abraham, L. Townsend, A. Lewis, 1974, Journal of medicinal chemistry.

Li+ and sickling of homozygous HbS cells.

D. Abraham, D. C. Patwa, 1985, Clinical chemistry.